EGFR and non-small cell lung carcinoma: Exon 19 deletions (19 Del) and exon 21 codon p.Leu858Arg (L858R) point mutations of the epidermal growth factor receptor have been shown to be significant predictors of response to EGFR tyrosine kinase inhibitors in NSCLC.